MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: seminole who wrote (142)	9/8/1997 10:43:00 PM
From: JOSEPH VON MEISTER	of 1826

Salagen is also a product like that. When Blitzer started he was concerned about the stock price - eventually he realized that the street was looking for results, not promises. So he is working on producing results. The list of milestones met during his short time here are long and impressive. How do you get a guy like Tim Rothwell (pres Rhone-Poulec US Pharma Ops) to fly to Minnesota for Board meetings in January. He is a busy guy. He is not interested in the directors fees. Collins is also a top guy... he was in line to run JNJ and did run McNeil for JNJ. Anyway, I have first hand experience with Blitzer and he seems to have strong leadership skills. If the stock were to go from $3.5 to $5 would that mean Blitzer is a good manager. I think if you look beneath the surface you will find an inefficiently priced stock managed by very capable people. JVM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next